Yu Yanyan, Xiang Yu, Liu Haican, Yang Shuliu, Li Machao, Liu Binbin, Xu Da, Wu Yaning, Li Wenbin, Fang Tanwei, Li Jixiang, Xu Donglei, Wan Kanglin, Tan Yunhong, Yuan Xiuqin, Li Guilian
Clinical Laboratory, Hunan Provincial Tuberculosis Prevention and Control Institute & Hunan Chest Hospital, Changsha, Hunan, China.
Institute of Reproduction and Stem Cell Engineering, School of Basic Medical Sciences, Central South University, Changsha, Hunan, China.
Front Public Health. 2024 Jul 17;12:1405358. doi: 10.3389/fpubh.2024.1405358. eCollection 2024.
This study aimed to investigate the epidemiological and drug resistance (DR) characteristics of extrapulmonary tuberculosis (EPTB) in South-Central China.
EPTB inpatients who were culture-positive for were retrospectively included in a study at a provincial TB hospital in Hunan, a province in South-Central China, from January 2013 to December 2021. Demographic, clinical, and drug susceptibility data were retrieved from TB treatment records. Descriptive statistical methods and a Chi-squared test were used to analyze the epidemiological and DR characteristics of EPTB patients. A logistic regression model was used to explore the risk factors of rifampicin-resistant/multidrug-resistant (RR/MDR)-EPTB.
A total of 1,324 cases were included. The majority of EPTB patients were in the age range of 20-29 years, were predominantly men (male-to-female ratio: 2.03), and were farmers (65.63%). Most EPTB cases were found in 2013 and 2017 from 2013 to 2021. The most prevalent subtypes of EPTB were lymphatic TB (29.83%, 395/1,324), multiple EPTB (20.85%, 276/1,324), and musculoskeletal TB (14.65%, 194/1,324). Musculoskeletal TB and genitourinary TB predominantly presented as exclusive EPTB forms, while lymphatic TB and pharyngeal/laryngeal TB often co-occurred with pulmonary TB (PTB). Drug susceptibility testing results showed that total DR rates (resistance to any of RFP, isoniazid [INH], streptomycin [STR], and/or ethambutol [EMB]) and RR/MDR rates in EPTB were 25.23% and 12.39%, respectively. Musculoskeletal TB exhibited the highest rates of total DR (31.40%), INH resistance (28.90%), STR resistance (20.10%), EMB resistance (6.20%), MDR (13.90%), and poly-DR (6.70%). The multivariable logistic regression model showed that patients aged from 20 to 59 years (compared to those aged 10 years), workers (compared to retirees), and EPTB patients from the south and west of Hunan (compared to those from the east of Hunan) were at an increased risk of developing RR/MDR EPTB (all values > 1).
Our study provided a detailed account of the epidemiological and DR characteristics of EPTB in Hunan province, China. The significant DR rates, particularly in musculoskeletal TB cases, highlight the need for timely diagnosis, effective drug susceptibility testing, and the development of more effective treatment regimens for EPTB, especially targeting musculoskeletal TB treatments.
本研究旨在调查中国中南部地区肺外结核(EPTB)的流行病学和耐药特征。
回顾性纳入2013年1月至2021年12月在中国中南部省份湖南省一家省级结核病医院进行培养阳性的EPTB住院患者。从结核病治疗记录中检索人口统计学、临床和药物敏感性数据。采用描述性统计方法和卡方检验分析EPTB患者的流行病学和耐药特征。使用逻辑回归模型探讨利福平耐药/耐多药(RR/MDR)-EPTB的危险因素。
共纳入1324例病例。大多数EPTB患者年龄在20-29岁之间,以男性为主(男女比例:2.03),职业为农民(65.63%)。2013年至2021年期间,大多数EPTB病例出现在2013年和2017年。EPTB最常见的亚型是淋巴结核(29.83%,395/1324)、多发EPTB(20.85%,276/1324)和肌肉骨骼结核(14.65%,194/1324)。肌肉骨骼结核和泌尿生殖系统结核主要表现为单纯的EPTB形式,而淋巴结核和咽喉结核常与肺结核(PTB)同时发生。药物敏感性测试结果显示,EPTB的总耐药率(对利福平、异烟肼[INH]、链霉素[STR]和/或乙胺丁醇[EMB]中任何一种耐药)和RR/MDR率分别为25.23%和12.39%。肌肉骨骼结核的总耐药率(31.40%)、INH耐药率(28.90%)、STR耐药率(20.10%)、EMB耐药率(6.20%)、MDR率(13.90%)和多药耐药率(6.70%)最高。多变量逻辑回归模型显示,年龄在20至59岁之间的患者(与10岁患者相比)、工人(与退休人员相比)以及来自湖南南部和西部的EPTB患者(与来自湖南东部的患者相比)发生RR/MDR EPTB的风险增加(所有P值>1)。
我们的研究详细描述了中国湖南省EPTB的流行病学和耐药特征。显著的耐药率,特别是在肌肉骨骼结核病例中,凸显了对EPTB进行及时诊断、有效的药物敏感性测试以及制定更有效治疗方案的必要性,尤其是针对肌肉骨骼结核的治疗。